CBT
CoreFirst Bank & Trust Portfolio holdings
AUM
$177M
This Quarter Return
-1.11%
1 Year Return
+12.47%
3 Year Return
+48.52%
5 Year Return
–
10 Year Return
–
AUM
$144M
AUM Growth
+$144M
(-1.8%)
Cap. Flow
-$3.88M
Cap. Flow
% of AUM
-2.69%
Top 10 Holdings %
Top 10 Hldgs %
33.09%
Holding
453
New
6
Increased
39
Reduced
62
Closed
8
Top Buys
| 1 |
AT&T
T
|
$342K |
| 2 |
ARK Innovation ETF
ARKK
|
$160K |
| 3 |
S&P Global
SPGI
|
$155K |
| 4 |
CSX Corp
CSX
|
$149K |
| 5 |
Visa
V
|
$142K |
Top Sells
| 1 |
GE Aerospace
GE
|
$3.57M |
| 2 |
Charles Schwab
SCHW
|
$278K |
| 3 |
Iron Mountain
IRM
|
$252K |
| 4 |
JPMorgan Chase
JPM
|
$221K |
| 5 |
Microsoft
MSFT
|
$156K |
Sector Composition
| 1 | Consumer Staples | 17.59% |
| 2 | Technology | 17.02% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Financials | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Intercontinental Exchange
ICE
$101B
| $325K | 0.23% |
2,830
| – | – |
|
102
Baxter International
BAX
$12.7B
| $324K | 0.22% |
4,026
-46
| -1% | -$3.7K |
|
103
Citigroup
C
$178B
| $315K | 0.22% |
4,489
| – | – |
|
|
NIE
104
Virtus Equity & Convertible Income Fund
NIE
$688M
| $313K | 0.22% |
10,618
| – | – |
|
105
Phillips 66
PSX
$54B
| $311K | 0.22% |
4,436
-753
| -15% | -$52.8K |
|
106
Ares Management
ARES
$39.3B
| $302K | 0.21% |
4,090
| – | – |
|
107
Novo Nordisk
NVO
$251B
| $300K | 0.21% |
3,120
-62
| -2% | -$5.96K |
|
108
Hanover Insurance
THG
$6.21B
| $291K | 0.2% |
2,247
-413
| -16% | -$53.5K |
|
109
Waste Management
WM
$91.2B
| $285K | 0.2% |
1,908
| – | – |
|
110
MetLife
MET
$54.1B
| $284K | 0.2% |
4,604
| – | – |
|
111
Zimmer Biomet
ZBH
$21B
| $284K | 0.2% |
1,943
| – | – |
|
112
Mondelez International
MDLZ
$79.5B
| $281K | 0.19% |
4,822
| – | – |
|
113
3M
MMM
$82.8B
| $275K | 0.19% |
1,568
-76
| -5% | -$13.3K |
|
114
DuPont de Nemours
DD
$32.2B
| $272K | 0.19% |
3,998
| – | – |
|
115
Edwards Lifesciences
EW
$47.8B
| $272K | 0.19% |
2,400
| – | – |
|
116
Ameren
AEE
$27B
| $271K | 0.19% |
3,340
| – | – |
|
117
Leggett & Platt
LEG
$1.3B
| $266K | 0.18% |
5,924
| – | – |
|
118
Enterprise Products Partners
EPD
$69.6B
| $255K | 0.18% |
11,774
+2,100
| +22% | +$45.5K |
|
119
Bunge Global
BG
$16.8B
| $248K | 0.17% |
3,050
| – | – |
|
120
Eli Lilly
LLY
$657B
| $231K | 0.16% |
1,000
| – | – |
|
121
Kinder Morgan
KMI
$60B
| $230K | 0.16% |
13,752
-354
| -3% | -$5.92K |
|
122
Allstate
ALL
$53.6B
| $229K | 0.16% |
1,796
| – | – |
|
|
123
CSX Corp
CSX
$60.6B
| $224K | 0.16% |
7,536
+5,024
| +200% | +$149K |
|
124
Gilead Sciences
GILD
$140B
| $223K | 0.15% |
3,199
| – | – |
|
125
Novartis
NVS
$245B
| $223K | 0.15% |
2,730
+595
| +28% | +$48.6K |
|